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Mitochondrial activity is controlled by proteins en-
coded by both nuclear and mitochondrial DNA.
Here, we identify Sirt7 as a crucial regulator of mito-
chondrial homeostasis. Sirt7 deficiency in mice
induces multisystemic mitochondrial dysfunction,
which is reflected by increased blood lactate levels,
reduced exercise performance, cardiac dysfunction,
hepatic microvesicular steatosis, and age-related
hearing loss. This link between SIRT7 and mitochon-
drial function is translatable in humans, where SIRT7
overexpression rescues the mitochondrial functional
defect in fibroblasts with a mutation in NDUFSI.
These wide-ranging effects of SIRT7 on mitochon-
drial homeostasis are the consequence of the deace-
tylation of distinct lysine residues located in the
hetero- and homodimerization domains of GABPb1,
a master regulator of nuclear-encodedmitochondrial
genes. SIRT7-mediated deacetylation of GABPb1
facilitates complex formation with GABPa and the
transcriptional activation of the GABPa/GABPb het-
erotetramer. Altogether, these data suggest that
SIRT7 is a dynamic nuclear regulator ofmitochondrial
function through its impact on GABPb1 function.
INTRODUCTION
Mitochondria are unique cellular organelles derived from endo-
symbiotic a-proteobacteria that evolved within our cells (Gray
et al., 1999). Mitochondria contain multiple copies of their own
circular DNA (mtDNA), which encodes for only 13 proteins.
Hence, the bulk of the mitochondrial proteins are encoded by
nuclear DNA (nDNA) and subsequently imported, folded, and
assembled within the mitochondria, exposing them to proteo-
toxic stress (Schmidt et al., 2010; Wallace, 1999). Mitochondria856 Cell Metabolism 20, 856–869, November 4, 2014 ª2014 Elsevierharvest energy from nutrients and convert it via oxidative phos-
phorylation (OXPHOS) into ATP, the cellular energy source, mak-
ing them also vulnerable to metabolic stress. This exposure to
distinct stressors explains the existence of multiple quality con-
trol mechanisms and adaptive pathways, including mitochon-
drial biogenesis, mitophagy, and the mitochondrial unfolded
protein response, which all act to maintain proper mitochondrial
function (Andreux et al., 2014; Poyton and McEwen, 1996).
Chronic overload of these quality control pathways is a major
cause for mitochondrial dysfunction and contributes to the path-
ogenesis of mitochondrial diseases, ranging from rare inherited
mitochondrial diseases to a palette of common age-related dis-
orders that include metabolic diseases, neurodegeneration, and
cancer (Larsson, 2010; Nunnari and Suomalainen, 2012; Wal-
lace, 1999). Many of the adaptive processes in the mitochondria
are governed by a small set of nuclear transcription factors,
including nuclear respiratory factor 1 (NRF1), GA binding protein
(GABP, also known as nuclear respiratory factor or NRF2 [NCBI
Gene Expression Omnibus (GEO) IDs 14390 for GABPa and
14391 for GABPb1] but not to be confused with Nrf2/Nfe2l2
[NCBI GEO ID 18024]) and nuclear receptors, such as the perox-
isome proliferator-activated receptors (PPARs) and estrogen-
related receptors (ERRs) as well as transcriptional coregulators,
such as PPARg coactivator 1a, nuclear receptor corepressor 1,
and the sirtuins (Andreux et al., 2013; Houtkooper et al., 2012;
Scarpulla, 2008).
The sirtuins, an evolutionarily conserved protein family
named after the prototypical yeast sirtuin enzyme Sir2p (Ivy
et al., 1985; Shore et al., 1984), are central regulators of mito-
chondrial homeostasis (Guarente, 2008; Haigis and Sinclair,
2010; Houtkooper et al., 2012). Mammals have seven sirtuins
(SIRT1–SIRT7) with distinct subcellular localization and biolog-
ical actions (Houtkooper et al., 2012). The enzymatic activity
of sirtuins is critically dependent on the obligatory cosubstrate
NAD+, making them intracellular sensors of the metabolic envi-
ronment (Houtkooper et al., 2010; Imai and Guarente, 2010).
The function of SIRT7, which, along with SIRT1 and SIRT6, is
present in the nucleus, is only partially understood. SIRT7 is
enriched in the nucleoli, where it facilitates the activation ofInc.
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SIRT7 Is a Deacetylase of GABPb1the DNA-dependent RNA polymerase I holoenzyme by inter-
acting with one of its subunits (Ford et al., 2006) and the up-
stream binding transcription factor (UBTF) (Grob et al., 2009)
and by the deacetylation of PAF53 (Chen et al., 2013). SIRT7
also deacetylates lysine 18 of histone H3, which is involved in
the stabilization of transformed cancer cells (Barber et al.,
2012), and Sirt7/ mice display cardiac hypertrophy, which
has been linked to p53 hyperacetylation (Vakhrusheva et al.,
2008). Interestingly, two very recent studies linked SIRT7 to
the control of liver function using independently generated
mouse models, though diametrically opposed effects on liver
lipid accumulation were observed (Shin et al., 2013; Yoshizawa
et al., 2014).
By the combination of bioinformatic, molecular, and in vivo
studies using independently generated germline- and liver-
specific Sirt7/ mouse models, we show that SIRT7 deacety-
lates GABPb1, thereby enabling it to form the transcriptionally
active GABPa/GABPb heterotetramer. Through this effect on
GABPb1 acetylation, SIRT7 is crucial for promoting proper
mitochondrial function and preventing mitochondrial-related
diseases.
RESULTS
Sirt7 Expression Positively Correlates with
nDNA-Encoded Mitochondrial Genes
As a first step for identifying functions of SIRT7, we applied a
reverse genetic approach with the GeneNetwork database
(www.genenetwork.org) (Andreux et al., 2012). The Sirt7 expres-
sion pattern in livers or hematopoietic cells varied across the
different BXD (Singer et al., 2004) or B6XBTBR-F2-ob/ob (F2)
(Keller et al., 2008) mouse strains (Figures S1A–S1C available
online). To identify putative targets of SIRT7, we selected those
strains showing the highest or lowest Sirt7 expression levels in
each data set (indicated in red or blue, respectively; Figures
S1A–S1C) and performed gene set enrichment analysis (GSEA;
www.broadinstitute.org/gsea). Interestingly, GSEA showed a
significant positive correlation between Sirt7 and the gene set
encompassing mitochondrial ribosomal proteins (MRPs; Fig-
ure 1A), whereas no correlation was observed with cytosolic
ribosomal proteins (CRPs; Figures 1B–1C and Table S1). Next,
to avoid possible inbreeding-related confounding factors poten-
tially present in the recombinant inbred BXD strains, we analyzed
the correlation of Sirt7 tomitochondrial genes in lungs of outbred
heterogeneous mice stocks (Valdar et al., 2006) and 457 human
liver biopsies (Schadt et al., 2008). Again, a highly significant
positive correlation between Sirt7 andMRP geneswas observed
in both the lungs of heterogeneous outbred mice strains (Figures
1D–1E and S1D and Table S2) and human liver biopsies (Figures
1F and S1E and Table S3). In addition, the expression of several
other nDNA-encodedmitochondrial genes such asClpp, Polrmt,
Mfn1, Fars2, Elac2, andNt5m also correlated positively withSirt7
(Figures 1D–1F and Tables S2 and S3).
Multisystemic Mitochondrial Dysfunction in
Sirt7–/– Mice
These results encouraged us to explore the role of SIRT7 in mito-
chondrial homeostasis with the use of a different Sirt7-deficient
mouse line (Sirt7/), which was generated by the targeted dele-Cell Mtion of exons 6–9 of the Sirt7 gene (see the Supplemental Infor-
mation). Exons 6–9 encode the sirtuin deacetylase domain; in
particular, exon 6 includes the putative proton acceptor histidine
188, the critical residue for the enzymatic activity of sirtuins
(Figure S2A). The offspring of heterozygous Sirt7 breeders
(Sirt7+/) were born under normal Mendelian (+/+:+/:/ =
22.8%:52.4%:24.9%) and sex ratio (male:female = 48%:52%;
Figure S2B).
A frequent feature of mitochondrial disease is the accumula-
tion of lactate in the blood (Chi et al., 1992). Therefore, we moni-
tored lactate and glucose levels in the basal state, during an
oral glucose tolerance test (OGTT), and after exercise. Although
basal lactate and glucose levels were not different between
genotypes, lactate, but not glucose, was higher in Sirt7/
mice after a glucose challenge (Figure 2A) and a 30 min tread-
mill run (Figure 2B). Consistent with increased lactate levels,
endurance performance was reduced in Sirt7/ mice (Fig-
ure 2C). Given that SIRT7 was undetectable in skeletal muscle
(Figure S2C), this phenotype likely originates from cardiac
dysfunction in our Sirt7/ mice, which was ascertained by a
comprehensive set of functional, molecular, and morphological
analyses (Figures S2D–S2M) and was consistent with a previ-
ous report in an independently generated SIRT7 knockout
mouse line (Vakhrusheva et al., 2008). The liver, the main tissue
for metabolic transformation, is also sensitive to mitochondrial
dysfunction. Although body weight and composition were indis-
tinguishable between both genotypes (Figures S2N and S2O),
livers of Sirt7/ mice were heavier because of microvesicular
hepatosteatosis, a hallmark of hepatic mitochondrial dysfunc-
tion (Figures 2D–2F) (Fromenty et al., 1997). In addition to
the microvesicular hepatosteatosis, plasma triglycerides and
free fatty acids were also elevated in Sirt7/ mice (Figures
2G and 2H).
Inherited forms of deafness as well as age-related hearing loss
are linked with mitochondrial dysfunction (Yamasoba et al.,
2007). Among all nuclear sirtuins, Sirt7 is highest expressed in
the inner ear (Ct values: Sirt1 = 29.18 ± 0.479, Sirt6 = 38.29 ±
1.162, and Sirt7 = 25.60 ± 0.343; Figure S2P). On the basis of
this finding, we analyzed the auditory brainstem response
(ABR), a standard electrophysiological test for auditory function.
Hearing loss usually initiates from the high-frequency region and
then extends to the low-frequency region (Hunter and Willott,
1987). ABR was not different in young Sirt7+/+ and Sirt7/
mice (Figure 2I, left and right). However, in older mice, Sirt7/
deficiency increased the ABR threshold at all the frequencies
(Figure 2I, right) although this was only evident for the highest fre-
quency (30 kHz) in wild-type (WT) littermates (Figure 2I, left).
Collectively, these phenotypic changes suggest that Sirt7/
mice suffer from a multisystemic mitochondrial dysfunction.
Perturbed OXPHOS Function in Sirt7–/– Mice
As a next step, we analyzed gene and protein expression in
different tissues. Although expression of several nDNA-encoded
mitochondrial transcripts was reduced in the heart, liver, inner
ear, bone-marrow-derived cells, and lung of Sirt7/ mice, the
expression of the CRP genes, such as Rpl32, Rpl24, and
Rps12, was not altered (Figures 3A and S3A–S3C). Expression
of the nDNA-encoded MRPL49, a component of the mitochon-
drial large ribosomal subunit, and ClpP, an ATP-dependent Clpetabolism 20, 856–869, November 4, 2014 ª2014 Elsevier Inc. 857
Figure 1. Sirt7 Correlates with Nuclear-Encoded Mitochondrial Genes
(A) GSEA of the gene expression profiles in livers of B6xBTBR-F2-ob/ob (F2) mice. The gene set encompassing mitochondrial ribosomal proteins has an
enrichment score = 0.55, nominal p = 0.02, false discovery rate (FDR) q = 0.05, and family-wise error rate p = 0.01.
(B) Corresponding heatmaps displaying the expression values forSirt7 (S7) and theMRP andCRPgenes in livers of BXD and F2 strains and in hematopoietic cells
(Hem) of the BXD strains.
(C) Volcano plots of the p values (Student’s t test) versus fold change in BXD and F2 livers and hematopoietic cells of the BXDs. MRP genes showing positive
correlations with statistically significant p values are represented in red. See Table S1.
(D) Covariation between mRNA expression of Sirt7 (x axis) and indicated mitochondrial genes (y axis) in lungs of heterogeneous mice stocks (n = 279). PCA
combined all positively correlated mitochondrial genes. See Table S2.
(E) Interaction network between Sirt7, MRPs, CRPs, and genes involved in mitochondrial function from the lung mRNA data set in heterogeneous mice stocks.
Positive (r > 0.5) and negative correlations (r <0.5, Pearson’s correlation coefficient) between the nodes are represented by red and green edges, respectively.
(F) Covariation between mRNA expression of Sirt7 (x axis) and each indicated gene (y axis) in the human livers (n = 427). See also Table S3, including Pearson’s r
correlation coefficient with corresponding p values.
Cell Metabolism
SIRT7 Is a Deacetylase of GABPb1protease, as well as the mtDNA-encoded MT-CO1 protein was
reduced in the heart and liver of Sirt7/ mice (Figures 3B and
3C). Other OXPHOS subunits, such as ATP5A and UQCRC2,
were only reduced in the heart and not in the liver (Figures 3B
and 3C). To verify whether the changes in individual OXPHOS
proteins impacted on the OXPHOS complexes, we performed
blue native PAGE (BN-PAGE). SIRT7 deficiency differently
affected OXPHOS composition in heart and liver. Complex IV
was decreased in both tissues, whereas complex III was stable.
Complexes I and II were slightly reduced in heart, whereas com-
plexes II and V were slightly reduced in liver (Figures 3D and 3E).
Moreover, complex I activity was clearly reduced during in-gel
activity assays in both heart and liver (Figures 3D–3E, bottom).
In line with the BN-PAGE results, respiration through complexes
I, II, and IV was reduced in heart, liver, inner ear, and lung tissues,
as determined by high-resolution respirometry (Figures 3F–3H
and S3D).858 Cell Metabolism 20, 856–869, November 4, 2014 ª2014 ElsevierMitochondrial Dysfunction Is Induced in a Cell-
Autonomous Fashion
Then, we tested whether the effect of SIRT7 on mitochondrial
function was cell autonomous. After infection of Sirt7-floxed
mouse embryonic fibroblasts (Sirt7L2/L2 MEFs) with a Cre-
recombinase (Ad-Cre), but not the control GFP-expressing
(Ad-GFP) adenovirus, mRNA levels of various mitochondrial
genes were reduced (Figure S4A). Moreover, nDNA-encoded
MRPL49 as well as mtDNA-encoded MT-CO1 and MT-ND1 pro-
teins were robustly reduced upon induction of Sirt7 deficiency in
primary mouse hepatocytes (Figure S4B). Although a recent
report suggested that SIRT7 suppresses ER stress in the liver
(Shin et al., 2013), the expression of the ER stress marker
GRP78/BiP was not altered in Sirt7-deficient primary hepato-
cytes (Figure S4B), suggesting that a different mechanism
underlies our phenotype. In addition, Sirt7-deficient hepato-
cytes also had a reduced oxygen consumption rate (OCR) inInc.
Figure 2. Sirt7 KO Mice Show the Hallmarks of Mitochondrial Disease
(A) Blood lactate (left) and glucose (right) levels before and during OGTT in 30-week-old male Sirt7+/+ (n = 11) and Sirt7/ (n = 12) mice.
(B) Exercise-induced blood lactate levels after a 30 min treadmill run in 34-week-old male Sirt7+/+ (n = 11) and Sirt7/ (n = 12) mice.
(C) Maximum endurancewas determined, and the running distance achieved by eachmouse is represented (Sirt7+/+, n = 10;Sirt7/, n = 10, 34-week-oldmales).
(D) Liver weights of Sirt7+/+ (n = 10) and Sirt7/ (n = 10) mice of 42 weeks of age normalized to body weight.
(E) Triglyceride (TG) content in Sirt7+/+ and Sirt7/ livers (n = 8 per group, 42-week-old males).
(F) Hematoxylin and eosin staining of representative 42-week-old male livers of the indicated genotype.
(G and H) Plasma TG (G) and free fatty acid levels (H) in Sirt7+/+ and Sirt7/ mice (n = 8 per group, 42-week-old males).
(I) ABR auditory thresholds were monitored at 5, 8, 10, 15, and 30 kHz (Sirt7+/+, n = 8; Sirt7/, n = 10).
Graphs in (B–E) and (G and H) are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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SIRT7 Is a Deacetylase of GABPb1low-glucose medium, whereas the glycolytic activity was un-
changed as measured through the extracellular acidification
rate (ECAR) (Figure S4C, left). In high glucose, ECAR was
increased, whereas OCR was unaltered (Figure S4C, right).
Cellular fatty acid uptake and ATP levels were reduced, whereas
more superoxide was produced, in Sirt7-deficient primary hepa-
tocytes (Figures S4D–S4F). Interestingly, no major alterations in
the levels of key enzymes involved in lipogenesis and fatty acid
oxidation (i.e., medium-chain acyl-CoA dehydrogenase and
acetyl-CoA carboxylase; Figure S4G) and of transcripts of lipo-
genesis, fatty acid oxidation, lipid uptake, lipid storage, and tri-
glyceride (TG) secretion genes were observed (Figure S4H).
In addition to primary hepatocytes, we also evaluated the cell-
autonomous effect of SIRT7 onmitochondrial function in primary
cardiomyocytes that were isolated from 1- to 2-day-old C57BL/
6J WT pups and infected with either shCtrl- or shSirt7-RNA-ex-
pressing adenoviruses. As in Sirt7-deficient primary hepato-
cytes, the expression level of nDNA-encoded mitochondrial
genes was clearly attenuated in Sirt7-deficient primary cardio-
myocytes (Figure S4I). Furthermore, levels of both nDNA-
(ClpP, UBQCR3, and SDHB) and mtDNA-encoded (MT-CO1)
mitochondrial proteins were reduced (Figure S4J), which trans-
lated into reduced complexes II and IV activity upon respirometry
performedwith homogenized lysates of primary cardiomyocytes
(Figure S4K).
A recent study used adeno-associated virus 8 (AAV8)-medi-
ated silencing of SIRT7 to support the cell-autonomous natureCell Mof its effects in vivo (Shin et al., 2013). Given that tail vein-injec-
tion of AAV8 infects various tissues besides the liver, including
heart, skeletal muscle, lung, and brain (Zincarelli et al., 2008),
we have chosen to generate liver-specific Sirt7 KO (Sirt7hep/)
mice in order to analyze its cell-autonomous effects. In full sup-
port of a cell-autonomous effect of SIRT7 onmitochondrial func-
tion, Sirt7hep/mice displayed similar clinical (e.g., normal body
weight with microvesicular steatosis; Figures 4A–4E), molecular
(e.g., reduction inMrpl49mRNA and MRPL49 and MT-CO1 pro-
tein expression; Figures 4F and 4G), and mitochondrial (reduc-
tion in mitochondrial complexes on BN-PAGE and in OXPHOS
complexes I, II, and IV activity; Figures 4H and 4I) phenotypic
alterations. However, we did not detect alterations in the expres-
sion of a comprehensive gene set involved in hepatic lipid meta-
bolism (Figure 4J).
SIRT7 Is a Dynamic Nuclear Protein
Although SIRT7 was initially identified as a nucleolar protein
(Ford et al., 2006), recent data have also attributed a role for
SIRT7 outside the nucleolus (Barber et al., 2012; Chen et al.,
2013; Pfister et al., 2008). We detected SIRT7 in both nucleoli
and extranucleoli fractions upon subnuclear fractionation (Fig-
ure 5A). Immunocytochemistry assays further supported the ex-
tranucleolar localization of SIRT7 (Figure 5B). To unequivocally
establish whether SIRT7 is a dynamic factor, we performed
fluorescence recovery after photobleaching (FRAP) assays.
SIRT7 showed a very high ‘‘diffusional mobility,’’ given thatetabolism 20, 856–869, November 4, 2014 ª2014 Elsevier Inc. 859
Figure 3. Lack of SIRT7 Triggers Mitochondrial Dysfunction
(A) mRNA levels of Sirt7,Mrpl49,Mrps5,Mrps9,Mrps12,Clpp,Polrmt,Mfn1, andRpl32 in heart, liver, and inner ear of 42-week-oldSirt7+/+ (n = 4) andSirt7/ (n =
5) male mice.
(B and C) Western blot analysis showing SIRT7, MRPL49, ATP5A, UQCRC2, MT-CO1, TOM40, and ClpP levels in heart (B) and liver (C) of 42-week-old male
Sirt7+/+ and Sirt7/ mice. HSP90 was used as a loading control.
(D and E) BN-PAGE of OXPHOS complexes (top) and complex I in-gel activity (bottom) in mitochondria isolated from heart (D) and liver (E) of 42-week-old male
Sirt7+/+ and Sirt7/ mice.
(F–H) Oxygen consumption rates (OCR) of heart (F; n = 5), liver (G; n = 5), and inner ear (H; n = 4 per genotype) tissues of 42-week-old Sirt7+/+ and Sirt7/male
mice were monitored with specific substrates for each OXPHOS complex.
Data in (A) and (F–H) are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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SIRT7 Is a Deacetylase of GABPb1approximately 50% of the initial fluorescence intensity was
recovered in 2 s after photobleaching SIRT7-GFP in both nucle-
oplasm and nucleoli (Figures 5C and S5A). These cellular studies
demonstrate that SIRT7 is a dynamic nuclear protein that is not
restricted to nucleoli.
Bioinformatic Analysis Links SIRT7 Tightly to GABPb1
On the basis of the striking correlations between the expression
of Sirt7 and mitochondrial genes, the mitochondrial dysfunction
inSirt7/mice, and the fact that SIRT7 is a dynamic nuclear fac-
tor, we hypothesized that SIRT7 might affect the expression of
nDNA-encoded mitochondrial genes by impacting on transcrip-
tion factors such as NRF1, GABPa, GABPb1, GABPb2, ERRa,
and ERRg (Scarpulla, 2008). Interestingly, the expression of860 Cell Metabolism 20, 856–869, November 4, 2014 ª2014 ElsevierSirt7 positively correlated with that of Gabpa, Gabpb1, Gabpb2,
and Esrrg, but not Nrf1 and Esrra (Figures 5D and S5B and Table
S4). Pearson’s and Spearman’s correlation coefficients indi-
cated that Sirt7, Gabpa, Gabpb1, Gabpb2, and Esrrg belong to
the same gene cluster (Figure 5E and Table S4), and principal
component analysis (PCA) confirmed the strong positive correla-
tion between Sirt7 and the components of the GABP complex
(GABPa, GABPb1, and GABPb2; Figure 5F). Finally, in a factor-
loading plot based on Pearson’s correlation coefficients,
Gabpb1was the strongest Sirt7 correlate (Figure 5G). In addition
to our bioinformatics analysis, we also reanalyzed data from
three independent studies (Barber et al., 2012; Hollenhorst
et al., 2009; Mercer et al., 2011). A recent genome-wide
chromatin immunoprecipitation sequencing (ChIP-seq) studyInc.
Figure 4. Sirt7hep–/– Mice Have Hepatic Mitochondrial Dysfunction
(A–C) Body weight (A), normalized liver weights (B), and hepatic TG content (C) of 55-week-old chow-fed male Sirt7hep+/+ (n = 5) and Sirt7hep/ (n = 7) mice.
(D and E) Hematoxylin and eosin (D) and Oil Red O staining (E) of representative 55-week-old male livers of the indicated genotype.
(F) Hepatic mRNA levels ofMRP, Polrmt, Tfam,Mfn1,Clpp,Hspe1,Hspc5,CRP, and Sirtuin genes were evaluated by quantitative RT-PCR (qRT-PCR; Sirt7hep+/+
n = 4 andSirt7hep/; n = 8, 55-week-oldmalemice;MRP,mitochondrial ribosomal proteins; Mt Txn,mitochondrial transcription related; Mt Quality, mitochondria
quality control related; and CRP, cytosolic ribosomal proteins). Abbreviations are the same as in Figures 3A and S3A.
(G) Western blot analysis showing SIRT7, MRPL49, various OXPHOS subunits, and TOM40 in liver of Sirt7hep+/+ and Sirt7hep/. HSP90 was used as a loading
control.
(H) BN-PAGE of hepatic OXPHOS complexes of the mice in (G).
(I) OCR of liver lysates from 42-week-old male Sirt7hep+/+ and Sirt7hep/ mice (n = 5 per group).
(J) Expression levels of hepatic genes involved in fatty acid and TG synthesis, fatty acid uptake, fatty acid oxidation, and TG secretion as evaluated by qRT-PCR
(Sirt7hep+/+ n = 4 and Sirt7hep/ n = 8, 55-week-old male mice).
Graphs in (A–C), (F), and (I–J) are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 5. SIRT7 Is a Dynamic Nuclear Protein Regulating Mitochondrial Target Genes
(A) Western blot assays demonstrating the subnuclear localization of SIRT7. Whole-cell lysate (WCL), nucleoli (N), and extranucleoli (Ex-N) fractions were pre-
pared from primary hepatocytes isolated from WT C57Bl/6J mice. B23 (also known as nucleophosmin) was used as a control for nucleoli, and histone H3 was
used as a loading control (NS; a nonspecific band).
(B) Confocal microscopy of HeLa cells showing endogenous SIRT7 in the nucleus. UBTF was used as a positive control of nucleoli, and the nucleus was stained
with DAPI.
(C) FRAP assay of SIRT7-GFP demonstrates the highly dynamic nature of SIRT7 in HEK293T cells. Time-series confocal images of SIRT7-GFP (left) and the
fluorescence quantification of bleached areas (nucleolus, n = 9, and nucleoplasm, n = 6). Unbleached control areas were used for normalization of fluorescence
intensity (right). Data shown as mean ± SEM.
(D and E) In order to evaluate a possible link between Sirt7 expression and key transcription factors that control mitochondrial activity, a correlation analysis with
gene expression data from the hippocampus, which contains all these nuclear factors (Figure S5B and Table S4) was performed. Correlation matrix (D) and
interaction network (E) showing correlations between Sirt7 and transcription factors involved in the expression of mitochondrial gene expression. Positive and
statistically significant Pearson’s correlation coefficients are represented by red edges (r = 0.5–1.0).
(F) PCA showing a significant positive correlation between the expression of Sirt7 and all three genes in the GABP complex.
(G) Factor-loading plot based on Pearson’s correlation coefficients highlighting that Gabpb1 is most related to Sirt7.
(H) Area-proportional Venn diagram representing common genes between SIRT7-ChIP-seq (Barber et al., 2012), GABPa-ChIP-seq (Hollenhorst et al., 2009), and
the human mitochondrial transcriptome data (Mercer et al., 2011).
See Table S5.
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SIRT7 Is a Deacetylase of GABPb1demonstrated that SIRT7 occupies the promoters of 232 mito-
chondrial genes (Figure 5H and Table S5), including the MRP
promoters (Barber et al., 2012). Another study demonstrated
that GABPa occupies the promoters of 389 mitochondrial genes
(Hollenhorst et al., 2009). Interestingly, 75% of SIRT7-occupied
genes were also identified in the GABPa-ChIP-seq. Moreover,
56% of the genes that are part of the human mitochondrial tran-
scriptome (Mercer et al., 2011) are covered in these independent
studies (Figure 5H and Table S5). In combination, these data862 Cell Metabolism 20, 856–869, November 4, 2014 ª2014 Elseviersuggest the existence of a link between SIRT7-GABP and the
control of mitochondrial gene expression.
SIRT7 Impacts on Mitochondrial Function via the
Deacetylation of GABPb1
To analyze whether there is a functional link between SIRT7 and
GABPb1, we compared the acetylation of immunoprecipitated
GABPb1-Myc protein in human embryonic kidney 293T
(HEK293T) cells overexpressing the nuclear sirtuins. Notably,Inc.
Figure 6. SIRT7 Is a Deacetylase of GABPb1
(A) Western blot assay displaying reduced GABPb1 acetylation in SIRT7-, but not SIRT1- or SIRT6-, overexpressing HEK293T cells.
(B) In vitro deacetylation assay demonstrating that p300 acetylates and SIRT7 deacetylates GABPb1.
(C) Nano-LC-MS/MS analysis showing SIRT7-dependent in vitro deacetylation of AcK69, AcK340, and AcK396 of GABPb1.
(D) Western blot assay demonstrating that, in contrast to theWTGABPb1 protein, the GABPb1-3KRmutant is not deacetylated in HEK293T cells overexpressing
SIRT7.
(E) Reduced p300-mediated acetylation and abolished SIRT7-dependent deacetylation of the GABPb1 3KR mutant relative to the WT GABPb1 protein during
in vitro acetylation/deacetylation studies.
(F–I) Western blot showing acetylated GABPb1, total GABPb1, SIRT7, and HSP90 (or GAPDH) expression in Sirt7 L2/L2 (F), Sirt1L2/L2 (G), and Sirt6L2/L2 (H) primary
hepatocytes infected with either an Ad-GFP or Ad-Cre adenovirus. Bar graphs (I) show the quantification of the relative acetylation level of GABPb1 in these Sirt1,
Sirt6, and Sirt7L2/L2 primary hepatocytes. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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SIRT7 Is a Deacetylase of GABPb1the level of acetylated GABPb1 was specifically reduced upon
overexpression of SIRT7 but not SIRT1 or SIRT6 (Figure 6A). In
addition, we observed a clear interaction between ectopically
expressed SIRT7-GFP andGABPb1-Myc in HEK293T cells, sug-
gesting that SIRT7 could act as a GABPb1 deacetylase (Fig-
ure S6A). To validate whether SIRT7 directly deacetylates
GABPb1, we performed an in vitro acetylation and deacetylation
assay. Although p300 robustly acetylated GABPb1, GCN5 and
P/CAF displayed moderate or undetectable acetylation activity
(data not shown). Notably, the strong p300-induced acetylation
of GABPb1 was reverted by SIRT7 (Figure 6B). Mass spectro-Cell Mmetric analysis identified three acetylated lysines (K69, K340,
and K369) in GABPb1 displaying SIRT7-dependent deacetyla-
tion (Figures 6C and S6B–S6C). We generated a nonacetylatable
GABPb1 mutant in which these three lysine residues were
replaced by arginines (GABPb1-3KR). Upon transfection of
HEK293T cells, the mutant GABPb1-Myc-3KR displayed low
acetylation levels in comparison to the GABPb1-Myc-WT pro-
tein, and SIRT7 was unable to further reduce acetylation
(Figure 6D). The same effect was observed in vitro, where
GST-GABPb1-3KR was poorly acetylated by p300, and SIRT7
had no deacetylase activity (Figure 6E). In addition, acetylatedetabolism 20, 856–869, November 4, 2014 ª2014 Elsevier Inc. 863
Figure 7. Deacetylation of GABPb1 Promotes GABP Complex Formation and Governs Mitochondrial Activity In Vivo
(A) Sequence alignment showing three conserved lysine residues (K69, K340, and K369) in GABPb1 of Homo sapiens, Pan troglodytes, Macaca mulatta, Canis
lupus,Bos taurus,Musmusculus,Rattus norvegicus,Gallus gallus, andDanio rerio (top). Sequence alignment of the homodimerization domain of mouseGABPb1
and GABPb2. The residues K340 and K369 are unique to GABPb1 (bottom).
(B and C) GST pulldown assays for comparing the heterodimerization between GABPa-FLAG with GST-GABPb1 or acetylated GST-GABPb1 (B) and the
homodimerization between GABPb1-FLAG with GST-GABPb1 or acetylated GST-GABPb1 (C). Acetylation of GABPb1 reduces the hetero- as well as homo-
dimerization in vitro. (Non; nonacetylated GABPb1; Ac, acetylated GABPb1).
(D) mRNA levels of Sirt7, Mrpl49, Mrps5, Mrps9, Polrmt, and Rps12 in transiently transfected AML12 mouse hepatocytes expressing either a control shRNA
(shCtrl), an shRNA targeting SIRT7 (shSirt7), or the shSirt7 in combination with a GABPb1 3KR (3KR) expression vector.
(E) Western blot assay showing SIRT7, HSP90, ATP5A UQCRC2, MT-CO1, TOM40, and GABPb1 proteins in AML12 cells in identical conditions as mentioned
in (D).
(F) Western blot showing endogenous acetylated GABPb1 levels in liver and heart of 42-week-old male Sirt7+/+ and Sirt7/ mice.
(G) Western blot assay showing reduced levels of SIRT7, ATP5A, and MT-CO1 proteins and increased acetylation levels of GABPb1 in livers of 6 hr refed (Refed)
versus 24 hr fasted (fast) 17-week-old male C57BL6/J mice.
(H) Western blot assay demonstrating reduced levels of SIRT7 and selected OXPHOS proteins and increased levels of GABPb1 acetylation in livers of 2-year-old
compared to 0.5-year-old male C57BL6/J mice.
(legend continued on next page)
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SIRT7 Is a Deacetylase of GABPb1GABPb1 levels were specifically increased in Sirt7-, but not
Sirt1- or Sirt6-, deficient primary hepatocytes (Figures 6F–6I).
These studies indicate that SIRT7 deacetylates GABPb1 on
three specific lysine residues.
Deacetylation of GABPb1 Promotes GABP Complex
Formation and Activation
Previous reports showed that K69 of GABPb1 is a critical residue
facilitating the heterodimerization with GABPa and docking on
DNA (Thompson et al., 1991), whereas the lysines K340 and
K369 in the C-terminal domain (CTD) mediate GABPb1 homodi-
merization (de la Brousse et al., 1994; Gugneja et al., 1995).
These lysines are conserved in all vertebrate orthologs of
GABPb1 (Figure 7A, top), whereas the two lysines in the CTD
are not conserved in GABPb2, which also interacts with GABPa
(Figure 7A, bottom). Notably, we found that heterodimerization
between GABPa and b1 (Figure 7B) and homodimerization of
GABPb1 (Figure 7C) were reduced upon acetylation of these ly-
sines. Then, we used a GABP-responsive luciferase reporter to
test the effect of SIRT7-dependent deacetylation of GABPb1
on its transcriptional activity. Therefore, murine AML12 hepato-
cyte cells were cotransfected with this GABP reporter and rele-
vant combinations of SIRT7, WT GABPb1, the nonacetylatable
GABPb1-3KR, or the acetylation-mimicking GABPb1-3KQ.
Notably, the nonacetylatable GABPb1-3KR mutant induced
GABP reporter activity to an equal extent as the coexpression
of SIRT7 and GABPb1, whereas the acetylation-mimicking
GABPb1-3KQ mutant failed to activate the reporter even in the
presence of SIRT7 (Figure S7A). In addition, the effect of overex-
pressing the GABPb1-3KRmutant was evaluated in AML12 cells
in which SIRT7 was silenced (Figures 7D and 7E). Consistent
with the results obtained in SIRT7-deficient tissues and cells,
transcripts and protein levels of key mitochondrial genes, were
reduced by the SIRT7 knockdown. The ectopic expression of
GABPb1-3KR in these SIRT7 silenced AML12 cells partially
rescued the expression of several mitochondrial transcripts,
including those encoding for MRP, Polrmt (Figure 7D), and the
MT-CO1 protein (Figure 7E). These findings underscore the
functional importance of the SIRT7-dependent GABPb1
deacetylation.
Complementary to these in vitro interaction and cell-based
studies, we next tested whether the acetylation levels of
GABPb1 also differ in vivo. As expected, endogenous acetyla-
tion levels of GABPb1 (Ac-GABPb1) were increased in hearts
and livers of germline Sirt7/ mice (Figure 7F) as well as those
of Sirt7hep/ mice in vivo (Figure S7B).
SIRT7/GABPb1 Signaling and the Control of
Mitochondrial Activity
Finally, we analyzed whether the SIRT7/GABPb1 axis could con-
trol mitochondrial activity under physiological challenges. Food(I) Oxygen consumption rates (OCR) were measured in human fibroblasts harborin
or Ad-SIRT7 adenovirus and grown in high glucose medium.
(J) Western blot assay showing increased OXPHOS in human fibroblasts harborin
used as a control.
(K) A schematic model summarizing how SIRT7 controls mitochondrial homeos
formation (based on a model shown in Thompson et al., 1991).
Graphs in (D) and (F–I) show mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Cell Mrestriction is known to induce the expression of OXPHOS genes
in the liver (Ba´ez-Ruiz et al., 2005). Interestingly, SIRT7 expres-
sion was increased, whereas GABPb1 acetylation was reduced
in livers of fasted mice (Figure 7G). This was accompanied with
induced MT-CO1 and ATPA5A levels. Reduced OXPHOS is
associated with age-related decline in organ function (Yen
et al., 1989). Previously, we also reported that OXPHOS is
reduced in livers of old mice (Houtkooper et al., 2011). Expres-
sion of SIRT7 and some OXPHOS subunits, including MT-CO1,
was robustly reduced, whereas Ac-GABPb1 levels were induced
in livers of 2-year- versus 6-month-old mice (Figure 7H). More-
over, adenoviral-mediated SIRT7 overexpression improved
OCR and expression of mitochondrial proteins in human fibro-
blasts harboring amutated NDUFSI (Figures 7I and 7J), testifying
that SIRT7 can also improve humanmitochondrial function. Alto-
gether, our data suggest that the SIRT7/GABPb1 signaling is
linked to mitochondrial function in different genetic and physio-
logical contexts.
DISCUSSION
Our work proposes that SIRT7 is a dynamic nuclear regulator of
mitochondrial homeostasis acting on GABPb1, a master re-
gulator of mitochondrial biogenesis and function. A series of
experimental observations led us to this conclusion. First, the
expression of Sirt7 is tightly correlated with the expression of
many genes involved in the control of mitochondrial homeosta-
sis. Second, from all the transcription factors known to regulate
mitochondrial biogenesis and function, including PPARs, ERRs,
NRF-1, and GABPs, SIRT7 expression tightly correlates only
with that of GABPs. Third, two independent genome-wide
ChIP-seq analyses suggest that SIRT7 and the GABP complex
co-occupy multiple promoters of nDNA-encoded mitochondrial
genes. Fourth, SIRT7 deacetylates GABPb1 in critical residues
including K69, which induces dimerization with GABPa (Batche-
lor et al., 1998), and K340 and K369, which stabilize GABPb ho-
modimerization (de la Brousse et al., 1994; Thompson et al.,
1991). Fifth, deletion of Sirt7 in the mouse induces multiple de-
fects in a wide range of tissues as a consequence of generalized
mitochondrial dysfunction. Finally, SIRT7/GABPb1 signaling is
involved inmitochondrial adaptation to physiological challenges,
such as fasting, feeding, and aging. In combination, these inde-
pendent lines of evidence indicate a major role of SIRT7 in the
nuclear control of mitochondrial homeostasis.
As stated above, the phenotype of Sirt7/ mice, character-
ized by lactate accumulation, reduced exercise performance,
cardiac dysfunction and hypertrophy, hepatic microvesicular
steatosis, and hearing defects, resembles the clinical abnormal-
ities observed in patients with mitochondrial disorders (Chinnery
et al., 1999; Fosslien, 2003; Leone and Kelly, 2011; Nunnari and
Suomalainen, 2012; Wallace, 1999; Yamasoba et al., 2007). Theg amutant NDUFS1 (BB2693: BoAI cells) infected with either a control Ad-GFP
g mutant NDUFS1, transduced with either Ad-SIRT7 adenovirus. Ad-GFP was
tasis via the deacetylation of GABPb1 and the regulation of GABP complex
etabolism 20, 856–869, November 4, 2014 ª2014 Elsevier Inc. 865
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study using an independently generated Sirt7/ mouse line
showing an increased rate of apoptosis in the myocardium
(Vakhrusheva et al., 2008). However, our data indicate that, aside
from regulating apoptosis, a pathway intimately linked to the
mitochondria, SIRT7 has a broader role in mitochondrial homeo-
stasis in the heart, through its impact on GABP activity. Hence, it
is plausible that altered cardiac mitochondrial homeostasis con-
tributes to the development of cardiac hypertrophy and dysfunc-
tion in the Sirt7/ mice (Fosslien, 2003; Leone and Kelly, 2011;
Wallace, 1999). The exercise intolerance in Sirt7/ mice was
most likely a consequence of cardiac problems, given that
Sirt7 is not or only marginally expressed in skeletal muscle.
Liver steatosis subsequent to reduced fatty acid oxidation
and, in particular, microvesicular steatosis, as observed in our
Sirt7/ mice, is likewise a known feature of mitochondrial
dysfunction (Fromenty et al., 1997). Two very recent studies
(Shin et al., 2013; Yoshizawa et al., 2014) reported opposite he-
patic phenotypes in Sirt7-deficient mice. Shin et al. (2013)
observed a fatty liver, whereas Yoshizawa et al. (2014) report
protection of their Sirt7-deficient mice against high-fat diet
(HFD)-induced hepatic lipid accumulation. Although the Sirt7-
deficient mouse lines and the proposed mechanisms in all three
studies are different, our results showing that aged Sirt7-defi-
cient mice fed a normal chow (NC) accumulate hepatic triglycer-
ides (Figures 2E and 2F) aremore consistent with the data of Shin
et al. (2013). The fact that Yoshizawa et al. (2014) measured far
fewer lipids in the livers of Sirt7-deficient mice under an HFD in
comparison to WT or Sirt7-deficient mice under NC as well as
the absence of acetylation changes in the proposed SIRT7
effector molecules makes their observations puzzling and
devoid of conclusive mechanistic support. Altogether, all these
phenotypic abnormalities in the Sirt7/ mouse line reflect a se-
vere multisystem mitochondrial dysfunction, supporting our
hypothesis that SIRT7 is intimately linked to mitochondrial
homeostasis.
From a more mechanistic point of view, the aforementioned
correlation between SIRT7 and nDNA-encoded mitochondrial
transcripts implies a more dynamic behavior of nuclear SIRT7,
which seems not to be restricted to the nucleoli as previously re-
ported (Ford et al., 2006; Grob et al., 2009). A purely nucleolar
localization would dismiss a possible involvement of SIRT7 in
the control of mRNA transcription and limit its function to the
control of nucleoli-derived transcripts such as noncoding rRNAs
and tRNAs. Using subnuclear fractionation, immunocytochem-
istry, and FRAP assays (Figures 5A–5C and S5), we confirmed
that SIRT7 can shuttle between different nuclear compartments
(Chen et al., 2013; Pfister et al., 2008). This dynamic nature of
SIRT7 in the nucleus mechanistically underpins also how
SIRT7 impacts on transcription factors involved in the control
of nDNA-encoded mitochondrial genes. Nevertheless, future
studies will be necessary to define whether the subnuclear local-
ization of SIRT7 is a regulated process.
Although the transcription of nDNA-encoded mitochondrial
genes involves several transcription factors, we established a
specific link between SIRT7 and the activity of GABPa/GABPb
heterotetramer. GABPa continuously occupies its response ele-
ments on nuclear-encoded mitochondrial target genes but only
induces their transcription when it forms the GABPa/GABPb het-866 Cell Metabolism 20, 856–869, November 4, 2014 ª2014 Elseviererotetramer (de la Brousse et al., 1994; Scarpulla, 2008; Thomp-
son et al., 1991; Virbasius et al., 1993). We demonstrated that
SIRT7 deacetylates three critical residues of GABPb1, K69,
K340, and K369, which are involved in the stabilization of the
GABPa/GABPb complex (de la Brousse et al., 1994; Gugneja
et al., 1995; Thompson et al., 1991). In particular, the hydrogen
bond between Q321 of GABPa and K69 of GABPb1 is vital for
the stabilization of the GABPa-DNA complex (Batchelor et al.,
1998), whereas K340 and K369, located in CTD of GABPb1, sta-
bilize GABPb1 homodimerization (de la Brousse et al., 1994;
Thompson et al., 1991). Interestingly, these two lysine residues
(K340 and K369) are conserved in GABPb1 but not GABPb2 (Fig-
ure 7A). The acetylation of these two lysine residues could hence
indicate a distinct role of GABPb1 from GABPb2. To our knowl-
edge, this is the first study to unequivocally demonstrate the
importance of acetylation on these lysine residues, which re-
duces GABPb1 homodimerization. Furthermore, our work
suggests a unique role of SIRT7 in the dynamic control of this
acetylation switch, which stabilizes DNA binding and activation
of the GABPa/GABPb heterotetramer. This switch also allows
the fine-tuning and synchronization of GABP activity with cellular
energy levels, given that the activity of SIRT7, like that of all sir-
tuins, is strictly NAD+-dependent (Haigis and Sinclair, 2010;
Houtkooper et al., 2010; Imai et al., 2000). Through the control
of the activity of the GABPa/GABPb heterotetramer, which is vi-
tal for the expression of many mitochondrial gene sets, SIRT7
acquires a dominant position in the hierarchy of mitochondrial
homeostasis.
This premise is not only corroborated by the phenotypic ab-
normalities seen in the Sirt7/ mouse (see above) but also by
a number of bioinformatic and physiological studies. The very
tight correlation between the expression of Sirt7 and that of
many mitochondrial genes in several human and mouse tissues
suggested a strong link between SIRT7 and mitochondrial activ-
ity (Figure 1). Many of the promoters of these mitochondrial pro-
teins, including the MRP gene set, Polrmt, Tfam, andMfn1, were
further occupied by SIRT7 in an independent genome-wide
ChIP-seq analysis in a human cell line (Barber et al., 2012).
Notably, GABPa was shown to be permanently located on the
promoter of many of the same genes that were occupied by
SIRT7 (Hollenhorst et al., 2009). These two independent ChIP-
seq analyses hence show that 75% of SIRT7-occupied genes
are also bound by GABPa. In addition, more than half of the
genes reported as being part of the mitochondrial transcriptome
(Mercer et al., 2011) are covered in these two independent ana-
lyses (Figure 5H and Table S5), illustrating the wide ranging
impact of the SIRT7/GABP tandem on the transcription of
nDNA-encoded mitochondrial proteins. Finally, the reactivity of
the SIRT7/GABP axis to physiological changes, such as fast-
ing/feeding and aging, provides yet another compelling argu-
ment for their connectivity to mitochondrial function. It is also
of note that the effect of the SIRT7/GABP signaling axis on mito-
chondrial function is amplified by their impact on the transcrip-
tion of mitochondrial ribosomal proteins.
In summary, our work identifies a critical role for SIRT7/
GABPb1 signaling in the control of mitochondrial function. Mech-
anistically, SIRT7 controls mitochondrial homeostasis by the de-
acetylation of GABPb1, which in turn triggers the formation of the
active GABPa/GABPb complex and enhance the expression ofInc.
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in mice leads to multisystemic mitochondrial dysfunction.
Furthermore, dynamic changes in SIRT7/GABPb1 signaling
might contribute to mitochondrial adaptation to physiological
challenges, such as fasting recovery and aging. In combination,
these genetic and physiological data underscore the importance
of SIRT7/GABPb1 signaling in mitochondrial homeostasis. A
notable example was provided by the recovery of respiration
rates and mitochondrial protein expression in fibroblasts of a
patient with a mutation in NDUFSI. Activation of the SIRT7/
GABPb1 regulatory axis may offer an interesting approach for
preventing and/or treating mitochondrial dysfunction in patients
with inherited or acquired mitochondrial diseases.
EXPERIMENTAL PROCEDURES
All procedures are described in detail in the Supplemental Information.
Bioinformatic Analyses
Bioinformatic analyses with GSEA (http://www.broadinstitute.org/gsea) and
GeneNetwork (http://www.genenetwork.org/) were performed as described
in previous studies (Andreux et al., 2012; Lagouge et al., 2006). All transcrip-
tome data sets were downloaded from GeneNetwork. Hepatic transcriptome
data came from B6xBTBR-F2-ob/ob (B6XBTBR-F2 liver mRNA M430 RMA),
BXD inbred mice (BXD GN373 GSE16780 UCLA Hybrid MDP-liver-Sep11
RMA), and a human population (the Human Liver Cohort). Hematopoietic
cell transcriptome data came from BXD inbred mice (UMCG Stem Cells
ILM6v1.1 original database). Lung transcriptome data came from heteroge-
neous stock mice (OX UK HS ILM6v1.1 lung RankInv). Hippocampus tran-
scriptome data came from the BXD inbred mice (Hippocampus Consortium
M430v2 PDNN).
In brief, GSEA was applied in these data sets as an unbiased bioinformatic
analysis in order to define gene sets showing statistical correlation with Sirt7
expression in both human and murine transcriptome data sets (Figures 1A–
1C). Volcano plots were prepared on the basis of fold change and Student’s
t test. Correlation analyses were based on both Pearson product-moment
correlation coefficient and Spearman’s rank correlation coefficient with the
GeneNetwork website (Figures 1D–1F and 5D–5H). The correlation analysis
between Sirt7 and specific transcription factors (NRF1, GABP complex,
ERRa, and ERRg) was performed only in the hippocampus, given that all tran-
scription factors are simultaneously expressed there, unlike in other tissues.
Animal Studies
Sirt7/ mice were generated by a classical gene targeting strategy in 129Sv
embryonic stem cells. Detailed information on gene targeting an be found in
the Supplemental Experimental Procedures. The Sirt7/ and Sirt7L2/L2 mice
were backcrossed for ten generations onto theC57BL/6J background. Pheno-
typing experiments were performed with validated Eumorphia /EMPReSS
standard operating protocols (www.eumorphia.org). Animal experiments
were approved by the ethics committee of the Canton of Vaud with permit
ID #2444.
In Vitro Acetylation and Deacetylation Assays
In vitro acetylation and deacetylation assays were performed as originally
described (Rothgiesser et al., 2010). In brief, 1 mg of recombinant GABPb1 pro-
tein obtained fromBL21 strain was incubated with 500 ng of recombinant p300
in acetylation buffer (50mMTris-HCl [pH 8], 100mMNaCl, 10%glycerol, 1mM
phenylmethylsulfonyl fluoride [PMSF], 1 mM dithiothreitol [DTT], 1 mg/ml bep-
statin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mM sodium butyrate, and
150 mM acetyl-CoA) for 1 hr at 30C. After incubation, samples were resolved
on SDS-PAGE and analyzed by western blot or used for in vitro deacetylation
assays. For deacetylation assays, 1 mg of acetylated GABPb1 was incubated
with 500 ng recombinant of SIRT7 protein in the deacetylation buffer (50 mM
Tris-HCl [pH 9], 4 mMMgCl2, 0.2 mM DTT, 1 mg/ml bepstatin, 1 mg/ml leupep-
tin, 1 mg/ml pepstatin, and 1 mMNAD+) for 30 min with constant agitation. The
incubated samples were resolved on SDS-PAGE and analyzed bywestern blotCell Mor used tomap an acetylated residuewith nano liquid chromatography tandem
mass spectrometry (LC-MS/MS). Recombinant proteins p300 and SIRT7 were
kindly supplied by Michael O. Hottiger (University of Zurich).
Mass Spectrometry
Gel lanes were cut into pieces and subjected to in-gel digestion with endopro-
teinase Glu-C or trypsin. Peptide digests were resuspended and analyzed by
nano LC-MS/MS with an Orbitrap Elite Mass Spectrometer (Thermo Fischer
Scientific) coupled to an ultraperformance LC system (Thermo Fischer Scien-
tific Ultimate 3000 RSLC). Data analysis was performed with Proteome
Discoverer (v. 1.3), and searches were performed with Mascot and Sequest
against a mouse database (UniProt release 2013_01). Data were further pro-
cessed, inspected, and visualized with Scaffold 3.
Statistical Analyses
The comparison of different groups was carried out with Student’s t test and
two-way ANOVA, and differences under p < 0.05 were considered statistically
significant (*p < 0.05, **p < 0.01, ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
seven figures, and six tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.08.001.
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